Back
Akari Therapeutics PLC Vs. Biodexa Pharmaceuticals PLC Industry Stock Comparison
Sell
40
AKTX
Akari Therapeutics PLC
Last Price:
2.23
Seasonality Move:
-3.74%
Sell
20
BDRX
Biodexa Pharmaceuticals PLC
Last Price:
5.73
Seasonality Move:
-31.36%
Sell
40
Akari Therapeutics PLC (AKTX)
is a Sell
Is Akari Therapeutics PLC a Buy, Sell or Hold?
- The current Akari Therapeutics PLC [AKTX] share price is $2.43. The Score for AKTX is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- AKTX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
20
Biodexa Pharmaceuticals PLC (BDRX)
is a Sell
Is Biodexa Pharmaceuticals PLC a Buy, Sell or Hold?
- The current Biodexa Pharmaceuticals PLC [BDRX] share price is $5.63. The Score for BDRX is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- BDRX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
AKTX Stock Price Chart
What is Akari Therapeutics PLC's stock price today?
-
The Akari Therapeutics PLC share price today is $2.43
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
BDRX Stock Price Chart
What is Biodexa Pharmaceuticals PLC's stock price today?
-
The Biodexa Pharmaceuticals PLC share price today is $5.63
The current trend is moderately bullish and BDRX is experiencing selling pressure, which indicates risk of future bearish movement.
AKTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.14 | Sell |
| Relative Strength Index (14 RSI): | 43.98 | Sell |
| Chaikin Money Flow: | 19777 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.29 - 2.89) | Sell |
| Bollinger Bands (100): | (2.71 - 3.71) | Sell |
BDRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.84 | Buy |
| Relative Strength Index (14 RSI): | 41.19 | Sell |
| Chaikin Money Flow: | -17064 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.81 - 7.23) | Buy |
| Bollinger Bands (100): | (-0.4 - 4.16) | Buy |
AKTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.46 | Sell |
| 20-day SMA: | 2.49 | Sell |
| 50-day SMA: | 2.98 | Sell |
| 200-day SMA: | 2.57 | Sell |
| 8-day EMA: | 2.46 | Sell |
| 20-day EMA: | 2.55 | Sell |
| 50-day EMA: | 2.82 | Sell |
| 200-day EMA: | 3.04 | Sell |
BDRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.13 | Sell |
| 20-day SMA: | 6 | Sell |
| 50-day SMA: | 2.96 | Buy |
| 200-day SMA: | 1.55 | Buy |
| 8-day EMA: | 5.99 | Sell |
| 20-day EMA: | 5.5 | Buy |
| 50-day EMA: | 3.83 | Buy |
| 200-day EMA: | 13.18 | Sell |
Akari Therapeutics PLC Earnings Growth & AKTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.60 per share, and a decrease next year of $0.00 per share.
Biodexa Pharmaceuticals PLC Earnings Growth & BDRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and an increase next year of $0.05 per share.
Akari Therapeutics PLC Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Biodexa Pharmaceuticals PLC Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||